Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Suppression of MCF-7 Breast Cancer Cell Multiplication by Alismatis rhizoma Extract

  • Da Hyun Kim (Department of Biomedical Laboratory Science, Kyungbok University) ;
  • Eun Ju Yang (Department of Biomedical Laboratory Science, Daegu Haany University) ;
  • Jeong Hyun Chang (Department of Biomedical Laboratory Science, Daegu Haany University)
  • Received : 2024.05.31
  • Accepted : 2024.09.09
  • Published : 2024.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to investigate the inhibitory effects of Alismatis rhizoma extract on breast cancer cell growth and elucidate the underlying mechanisms. The growth inhibitory effects of Alismatis rhizoma extract on breast cancer cells were measured using the WST-1 assay, while its impact on relevant proteins and genes was analyzed using real-time polymerase chain reaction. The results demonstrated significant inhibition of breast cancer cell growth by Alismatis rhizoma, with the inhibitory effect showing a positive correlation with the dosage, treatment duration, and quantity. Furthermore, Alismatis rhizoma extract markedly decreased the expression levels of cell cycle protein D1 and suppressed cell migration and invasion. In conclusion, Alismatis rhizoma exhibits the potential to inhibit breast cancer cell growth, possibly by regulating cell cycle progression and inhibiting cell migration and invasion. These findings suggest that Alismatis rhizoma extract possesses anticancer properties against human breast cancer cells. Further investigation of its reuglation of action will provide foundational data, potentially paving the way for its development as an anticancer therapeutic agent.

Keywords

References

  1. Bailly C. Pharmacological properties and molecular targets of alisol triterpenoids from Alismatis rhizoma. Biomedicines. 2022. 10.
  2. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: Current advances and future directions. Int J Med Sci. 2012. 9: 193-199.
  3. Batlle E, Massague J. Transforming growth factor-beta signaling in immunity and cancer. Immunity. 2019. 50: 924-940.
  4. Elkaeed EB, Salam H, Sabt A, Al-Ansary GH, Eldehna WM. Recent advancements in the development of anti-breast cancer synthetic small molecules. Molecules. 2021. 26.
  5. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, Soerjomataram I. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: A population-based study. Lancet Glob Health. 2023. 11: e1700-e1712.
  6. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast cancer statistics, 2022. CA Cancer J Clin. 2022. 72: 524-541.
  7. Ji X, Chen J, Ye J, Xu S, Lin B, Hou K. Epidemiological analysis of global and regional lung cancer mortality: Based on 30-year data analysis of global burden disease database. Healthcare (Basel). 2023. 11.
  8. Kim DH, Lee HW, Park HW, Lee HW, Chun KH. Bee venom inhibits the proliferation and migration of cervical-cancer cells in an hpv e6/e7-dependent manner. BMB Rep. 2020a. 53: 419-424.
  9. Kim DH, Lee S, Kang HG, Park HW, Lee HW, Kim D, Yoem DH, Ahn JH, Ha E, You WK, Lee SH, Kim SJ, Chun KH. Synergistic antitumor activity of a dll4/vegf bispecific therapeutic antibody in combination with irinotecan in gastric cancer. BMB Rep. 2020b. 53: 533-538.
  10. Kim DH, Yang EJ, Lee JA, Chang JH. Ginkgo biloba Leaf Extract Regulates Cell Proliferation and Gastric Cancer Cell Death. Korean Journal of Biochemistry and Molecular Biology. 2022. 28: 92-100.
  11. Montalto FI, De Amicis F. Cyclin d1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 2020. 9.
  12. Nawara HM, Afify SM, Hassan G, Zahra MH, Seno A, Seno M. Paclitaxel-based chemotherapy targeting cancer stem cells from mono- to combination therapy. Biomedicines. 2021. 9.
  13. Shibuya M. Vascular endothelial growth factor (vegf) and its receptor (vegfr) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011. 2: 1097-1105.
  14. Wang L, Jiang Y, Han T, Zheng C, Qin L. A phytochemical, pharmacological and clinical profile of paederia foetida and p. Scandens. Nat Prod Commun. 2014. 9: 879-886.
  15. Xu Y, Gong M, Wang Y, Yang Y, Liu S, Zeng Q. Global trends and forecasts of breast cancer incidence and deaths. Sci Data. 2023. 10: 334.
  16. Zhang LL, Xu W, Xu YL, Chen X, Huang M, Lu JJ. Therapeutic potential of rhizoma alismatis: A review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology. Ann N Y Acad Sci. 2017. 1401: 90-101.
  17. Zhou X, Luo J, Lin S, Wang Y, Yan Z, Ren Q, Liu X, Li X. Efficacy of poria cocos and Alismatis rhizoma against diet-induced hyperlipidemia in rats based on transcriptome sequencing analysis. Sci Rep. 2023. 13: 17493.